Skip to main content

Table 1 Descriptive statistics of patient characteristics at pre-treatment clinic visit

From: Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome

MeasureLovastatinPlaceboP value
N, enrolled1416 
N, incomplete20 
Age13.86 ± 2.1413.17 ± 2.540.4307
Sex0.2092
 Male1216
 Female20
Race/ethnicity0.05
 Caucasian1410
 Hispanic04
 African American01
 Asian01
Leiter-R Brief IQ standard score44.00 ± 9.2243.13 ± 6.240.7604
Leiter-R growth score461.40 ± 13.32462.30 ± 8.570.8273
ADOS-2 comparison score6.85 ± 2.546.75 ± 2.050.911
Parent education level0.764
 HS grad/GED01
 BA/BS56
 Master’s degree +44
 Some college25
 Some grad work10